• COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Search Library
Some patients with asthma are affected… SEVERELY!
In March we travelled to the UK and kicked-off our new project “Severely, Asthma!”, a video series that explores the different issues impacting the life of severe asthma patients. Severe asthma is sub ...

Read more

EMA update on medicines for COPD and eczema
The European Medicines Agency Committee for Medical Products for Human Use (CHMP), responsible for human medicines, has granted a positive opinion on the medical products Riarify and Trydoni ...

Read more

Sign the EU Manifesto on Influenza Vaccination
On March 12, EFA launched a 10-point Manifesto calling the EU for more action to increase seasonal influenza vaccination coverage rates in Europe. Influenza is annually responsible for 650 thousand de ...

Read more

Patients’ safety and public health post-Brexit
On the 21st of February, EFA Director of Policy and Strategy Roberta Savli participated in an event organised by a broad coalition of public health actors on the need to prioritise patients’ safety  ...

Read more

EFA Patients at BBMRI-ERIC Stakeholder Forum
EFA's Roberta Savli participated on the 25th of January in the Stakeholder Forum meeting of the BBMRI-ERIC. The meeting served to identify the priorities of action and to organize and agree on the wor ...

Read more

Amsterdam will be the European city for the evaluation of medicines
The European Medicines Agency (EMA) will move from London to Amsterdam (The Netherlands) by March 2019. The EMA is the EU agency in charge of medicines evaluation and safety monitoring.  The relo ...

Read more

Patients organisations, their added value and importance in decision-making
In November, the European Patients’ Forum (EPF) published the report gathering key insights and opinions from the European patients’ movement, including EFA’s, demonstrating the added-value through th ...

Read more

Digital Health becomes a priority for the European Medicines Agency
In October the European Medicines Agency launched a new topic group on digital health that will provide insights and recommendations to the agency on how to tackle the digital dimension of medicines a ...

Read more

Patients and healthcare professionals discussed our role in antimicrobial resistance at the EMA
EFA Vice President Erna Botjes attended three important meetings at the European Medicines Agency: a workshop on antimicrobial resistance, the joint and regular meeting of patients and healthcare prof ...

Read more

New updates on U-BIOPRED, supported by EFA
The U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) outcomes, in which EFA contributed, have been summarised in an interview published by European Respiratory & Pulmo ...

Read more

EFA at the leading respiratory (ERS) and dermatology (EADV) conferences
EFA will participate this September in two leading respiratory and dermatology conferences, where we will expose our projects and bring our patients perspective to those fields.  From the 9 to 13 ...

Read more

EFA brought the patient perspective to the Bavarian State Ministers for Health and Care panel discussion
EFA’s Susanna Palkonen represented the patient view for us and the European Patients' Forum in a panel discussion “The access to medicines – Challenges and perspectives for Europe” hosted by the Bavar ...

Read more

More Europe for better innovation for health and wellbeing
Europe is in an ideal position to take the leading role health and wellbeing’ according to the new editorial of Progress and Preventive Medicine “Viva Europa, a land of excellence in research and inno ...

Read more

EFA 2020 - The future of allergy, asthma and COPD patients Europe
Updating and upgrading EFA priorities 2020. AGM, Florence, 22May 2017 Stanimir Hasurdjiev, Patient Access Partnership PACT and European Patient’s Forum representative presented on patient involvemen ...

Read more

MyAirCoach presented at eHealth Week
New technologies can revolutionise the healthcare system, providing a better delivery of services and developing effective health policy. We are now able to access and share personal health data, thus ...

Read more

United Action for Allergy and Asthma
A political Call to Action in Europe Allergy and asthma are among the most frequent chronic diseases in the European Union (EU). Over 150 million EU citizens – almost one in three people – suffer fr ...

Read more

Patients and consumers remind on key requirements for the re-location of the European Medicines Agency
On April 25th 14 Members of the Patients and Consumers Working Party (PCWP) of the European Medicines Agency (EMA) sent a letter the Health Commissioner, the President of the European Council and the  ...

Read more

The first EP event of the year put the focus on health: Act. Believe. Care.
Chronic respiratory diseases need public policy solutions at European level to respond to increasing disease prevalence, unmet treatment needs, high cost of hospitalisations, work and school sick-leav ...

Read more

IMI looks into what patients bring to medicines
The Innovative Medicines Initiative launched in December its 10th call for proposals under IMI 2. We especially welcome one of the topics of this call: “Patient Perspectives in medicines lifecycle”. T ...

Read more

First congress of allergy respiratory patients in Spain
On the occasion of World COPD Day EFA Spanish Member FENAER, organized the First Congress of Allergy and Respiratory Patients in Madrid. During the event, FENAER presented the outcome of their latest  ...

Read more